FDA Inspection
LTS Lohmann Therapie-Systeme AGLTS Lohmann Therapie-Systeme AG – FDA Inspection, May 18, 2022
Record Details
This FDA Inspection record concerns LTS Lohmann Therapie-Systeme AG, with an inspection on May 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 18, 2022
- Product Type
- Drugs
View Company Profile
ID · 38c1a61e-6d92-4e67-9ac4-31ad61a95b26
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1264907
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of LTS Lohmann Therapie-Systeme AG
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 18, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LTS Lohmann Therapie-Systeme AG
- FDA Inspection 1116639 - 2019-10-31
- FDA Inspection 1025276 - 2017-09-15
- FDA Inspection 865616 - 2013-12-20
- FDA Inspection 735498 - 2011-06-21
- FDA Inspection 605480 - 2009-06-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.